Date published: 2026-11-12

1-800-457-3801

SCBT Portrait Logo
Seach Input

2,5-Dichloro-N-[2-(isopropylsulfonyl)phenyl]pyrimidin-4-amine (CAS 761440-16-8)

0.0(0)
Write a reviewAsk a question
Alternate Names:
(2,5-Dichloropyrimidin-4-yl)[2-[(propan-2-yl)sulfonyl]phenyl]amine
CAS Number:
761440-16-8
Molecular Weight:
346.23
Molecular Formula:
C13H13Cl2N3O2S
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.
* Refer to Certificate of Analysis for lot specific data.

QUICK LINKS

2,5-Dichloro-N-[2-(isopropylsulfonyl)phenyl]pyrimidin-4-amine is a compound of particular interest in the development of new organic semiconductors. Its pyrimidin-4-amine core is structurally analogous to building blocks of high-performance electronic materials, and the electron-withdrawing dichloro groups may enhance its electrical properties. Research on this compound often focuses on its integration into conjugated systems, which are critical for creating organic photovoltaic cells and thin-film transistors. The isopropylsulfonylphenyl moiety offers a handle for further chemical modification, potentially improving solubility and processability in film formation. Studies involving this molecule also delve into its role as a precursor for the synthesis of advanced polymers and molecular sensors, leveraging the reactivity of the sulfonyl group to introduce additional functional moieties.


2,5-Dichloro-N-[2-(isopropylsulfonyl)phenyl]pyrimidin-4-amine (CAS 761440-16-8) References

  1. Synthesis and anticancer activities of ceritinib analogs modified in the terminal piperidine ring.  |  Wang, P., et al. 2015. Eur J Med Chem. 93: 1-8. PMID: 25644671
  2. Discovery of novel tetrahydroisoquinoline-containing pyrimidines as ALK inhibitors.  |  Achary, R., et al. 2016. Bioorg Med Chem. 24: 207-19. PMID: 26712094
  3. Replacing the terminal piperidine in ceritinib with aliphatic amines confers activities against crizotinib-resistant mutants including G1202R.  |  Mathi, GR., et al. 2017. Eur J Med Chem. 126: 536-549. PMID: 27915169
  4. Discovery of novel 2,4-diarylaminopyrimidine analogues as ALK and ROS1 dual inhibitors to overcome crizotinib-resistant mutants including G1202R.  |  Wang, Y., et al. 2018. Eur J Med Chem. 143: 123-136. PMID: 29174809
  5. Design and synthesis of novel pyrimidine derivatives as potent antitubercular agents.  |  Liu, P., et al. 2019. Eur J Med Chem. 163: 169-182. PMID: 30508666
  6. XHL11, a novel selective EGFR inhibitor, overcomes EGFRT790M-mediated resistance in non-small cell lung cancer.  |  Li, Y., et al. 2021. Eur J Pharmacol. 907: 174297. PMID: 34217707
  7. Design, synthesis and biological evaluation of 2,4-pyrimidinediamine derivatives as ALK and HDACs dual inhibitors for the treatment of ALK addicted cancer.  |  Guo, D., et al. 2022. J Enzyme Inhib Med Chem. 37: 2512-2529. PMID: 36100230

Ordering Information

Product NameCatalog #UNITPriceQtyFAVORITES

2,5-Dichloro-N-[2-(isopropylsulfonyl)phenyl]pyrimidin-4-amine, 1 g

sc-499991
1 g
$184.00

2,5-Dichloro-N-[2-(isopropylsulfonyl)phenyl]pyrimidin-4-amine, 5 g

sc-499991A
5 g
$398.00